Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-06

Clinical Trial Update: Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol [NA]

View source ↗

Summary

A clinical trial comparing eldecalcitol to alfacalcidol for glucocorticoid-induced osteoporosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfacalcidol (alfacalcidol)
  • Eldecalcitol (eldecalcitol)

Snippet

Sponsor: e-GLORIA trial Protocol Review Committee | Conditions: Osteoporosis | NA | Status: UNKNOWN